{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:08:50Z","timestamp":1792238930347,"version":"4.4.0"},"reference-count":220,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hematologic malignancies (HMs), which originate from hematopoietic or lymphoid tissues, pose a significant therapeutic challenge due to issues such as drug resistance, relapse, and treatment-related toxicity. The tumor microenvironment (TME), especially within the bone marrow niche, is now widely recognized as a critical determinant of disease progression and treatment response. A central mechanism within this specialized niche is the extensive metabolic reprogramming of key stromal and immune cells, including tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), cancer-associated fibroblasts (CAFs), and bone marrow adipocytes (BMAds). This review systematically elaborates on the alterations in glucose, lipid, and amino acid metabolism within these cellular compartments of the HM-TME. We detail how metabolites such as lactate, fatty acids, and itaconate function not merely as metabolic byproducts but as active signaling molecules that drive critical processes like immune cell polarization, stromal remodeling, and intricate metabolic crosstalk. This comprehensive reprogramming collectively fosters a profoundly immunosuppressive milieu, promotes tumor cell survival and proliferation, and confers resistance to conventional and novel therapies. Furthermore, we explore emerging therapeutic strategies designed to target these metabolic vulnerabilities. These include inhibitors of specific metabolic pathways, modulators of metabolite-driven signaling, and innovative approaches such as nanomedicine and metabolically enhanced immunotherapy. Finally, we outline the current challenges in the field\u2014such as intra-tumoral metabolic heterogeneity and the pressing need for targeted delivery systems\u2014and discuss future perspectives involving advanced technologies like single-cell metabolomics and rational combination strategies. In summary, this synthesis aims to provide a comprehensive and rational foundation for developing novel immunometabolic interventions against HMs, highlighting the therapeutic potential of disrupting the metabolic dialogue within the TME.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1773233","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:03:29Z","timestamp":1774368209000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic reprogramming in tumor-associated cells of hematologic malignancies: mechanisms, crosstalk networks, and therapeutic implications in the tumor microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Zikun","family":"Hong","sequence":"first","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehu","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic Malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34243","article-title":"Therapy resistance mechanisms in hematological Malignancies","volume":"152","author":"Hofmann","year":"2023","journal-title":"Int J Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.195396","article-title":"Updates on the hematologic tumor microenvironment and its therapeutic targeting","volume":"104","author":"Forte","year":"2019","journal-title":"Haematologica"},{"key":"B5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological Malignancies","volume":"20","author":"M\u00e9ndez-","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136857","article-title":"The role of hypoxic bone marrow microenvironment in acute myeloid leukemia and future therapeutic opportunities","volume":"22","author":"Bruno","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18748","article-title":"Turning the spotlight on bone marrow adipocytes in haematological Malignancy and non-malignant conditions","volume":"201","author":"Austin","year":"2023","journal-title":"Br J Haematol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-24-52","article-title":"Relationship between adipocytes and hematological tumors in the bone marrow microenvironment: a literature review","volume":"13","author":"Li","year":"2024","journal-title":"Transl Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.14198","article-title":"Bone marrow adipocyte: Origin, biology and relationship with hematological Malignancy","volume":"46","author":"Wang","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40164-022-00296-9","article-title":"Myeloid-derived suppressor cells in hematologic Malignancies: Two sides of the same coin","volume":"11","author":"Yu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1129343","article-title":"Modulation of T-cell function by myeloid-derived suppressor cells in hematological Malignancies","volume":"11","author":"Bhardwaj","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1655005","article-title":"Metabolic reprogramming and immune regulation in acute myeloid leukemia","volume":"16","author":"Hao","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e71244","DOI":"10.1002\/cam4.71244","article-title":"Metabolic reprogramming of cancer cells and therapeutics targeting cancer metabolism","volume":"14","author":"Punnasseril","year":"2025","journal-title":"Cancer Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40164-022-00332-8","article-title":"The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia","volume":"11","author":"Xu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tibs.2023.03.004","article-title":"The metabolic cross-talk between cancer and T cells","volume":"48","author":"Cadenas-De Miguel","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200924","article-title":"Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia","volume":"218","author":"Stuani","year":"2021","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15981","article-title":"The hypoxia signalling pathway in haematological Malignancies","volume":"8","author":"Irigoyen","year":"2017","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2023.101669","article-title":"Metabolic crosstalk between stromal and Malignant cells in the bone marrow niche","volume":"18","author":"Tirado","year":"2023","journal-title":"Bone Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12964-023-01282-2","article-title":"The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways","volume":"21","author":"Bakhtiyari","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci Adv"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-20-0111","article-title":"Lactate-modulated immunosuppression of myeloid-derived suppressor cells contributes to the radioresistance of pancreatic cancer","volume":"8","author":"Yang","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2023.03.008","article-title":"Glucose metabolism of TAMs in tumor chemoresistance and metastasis","volume":"33","author":"Liu","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-023-2747-0","article-title":"Lactate decreases bortezomib sensitivity and predicts poor clinical outcomes of multiple myeloma","volume":"43","author":"Ma","year":"2023","journal-title":"Curr Med Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-025-06691-6","article-title":"Lactic acidosis as the initial presentation of lymphoma: A case report and integrated analysis of clinical characteristics and prognostic factors","volume":"104","author":"Zhang","year":"2025","journal-title":"Ann Hematol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211067749","article-title":"Type B lactic acidosis associated with diffuse large B-cell lymphoma and the Warburg effect","volume":"50","author":"Wang","year":"2022","journal-title":"J Int Med Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111765","article-title":"Lactate acid promotes PD-1+ Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia","volume":"130","author":"Zhang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.118604","article-title":"Aerobic glycolysis is a metabolic requirement to maintain the M2-like polarization of tumor-associated macrophages","volume":"1867","author":"de-Brito N","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1186\/s12885-025-14938-8","article-title":"Deciphering lactate\/lactylation networks in AML: integrated scRNA-seq and transcriptomics reveal functions and prognostic model","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1494788","article-title":"Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1480884","article-title":"How lactate affects immune strategies in lymphoma","volume":"11","author":"Zhou","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-024-00605-w","article-title":"Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma","volume":"12","author":"Dai","year":"2024","journal-title":"biomark Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016400","article-title":"Elevated lactate in AML bone marrow contributes to macrophage polarization via GPR81 signaling","volume":"10","author":"Soto","year":"2026","journal-title":"Blood Adv"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91154","article-title":"Tumor-derived exosomal ENO2 modulates polarization of tumor-associated macrophages through reprogramming glycolysis to promote progression of diffuse large B-cell lymphoma","volume":"20","author":"Shao","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12785","article-title":"Loss of bcl-3 regulates macrophage polarization by promoting macrophage glycolysis","volume":"102","author":"Liu","year":"2024","journal-title":"Immunol Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1133","article-title":"Targeting cancer cells and tumor microenvironment in preclinical and clinical models of hodgkin lymphoma using the dual PI3K\u03b4\/\u03b3 Inhibitor RP6530","volume":"25","author":"Locatelli","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40364-021-00333-5","article-title":"Landscape of myeloid-derived suppressor cell in tumor immunotherapy","volume":"9","author":"Hao","year":"2021","journal-title":"biomark Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-019-0797-3","article-title":"Myeloid-derived suppressor cells in hematological Malignancies: friends or foes","volume":"12","author":"Lv","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.060063","article-title":"Plasticity of myeloid-derived suppressor cells in cancer and cancer therapy","volume":"33","author":"Lv","year":"2025","journal-title":"Oncol Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e13388","DOI":"10.1111\/cpr.13388","article-title":"Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma","volume":"56","author":"Barbato","year":"2023","journal-title":"Cell Prolif"},{"key":"B47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41590-024-02068-5","article-title":"The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer","volume":"26","author":"He","year":"2025","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221924","article-title":"Emerging role of extracellular pH in tumor microenvironment as a therapeutic target for cancer immunotherapy","volume":"13","author":"Rahman","year":"2024","journal-title":"Cells"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690068","article-title":"Lactylation and antitumor immunity","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115432","article-title":"The tumor microenvironment is an ecosystem sustained by metabolic interactions","volume":"44","author":"Kay","year":"2025","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7150\/thno.62378","article-title":"Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-0019","article-title":"Targeting metabolic dependencies fueling the TCA cycle to circumvent therapy resistance in acute myeloid leukemia","volume":"84","author":"Bo\u00ebt","year":"2024","journal-title":"Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1038\/s41467-022-29639-0","article-title":"Inhibition of the succinyl dehydrogenase complex in acute myeloid leukemia leads to a lactate-fuelled respiratory metabolic vulnerability","volume":"13","author":"Erdem","year":"2022","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-1014-0","article-title":"ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts","volume":"39","author":"Sung","year":"2020","journal-title":"Oncogene"},{"key":"B56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-024-01910-x","article-title":"MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p","volume":"10","author":"Affinito","year":"2024","journal-title":"Cell Death Discov"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-019-00426-2","article-title":"Clinical significance of metabolism-related biomarkers in non-hodgkin lymphoma \u2013 MCT1 as potential target in diffuse large B cell lymphoma","volume":"42","author":"Afonso","year":"2019","journal-title":"Cell Oncol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12967-025-06083-4","article-title":"Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis","volume":"23","author":"Spampinato","year":"2025","journal-title":"J Transl Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"qzaf029","DOI":"10.1093\/gpbjnl\/qzaf029","article-title":"Glycolysis induces abnormal transcription through histone lactylation in T-cell acute lymphoblastic leukemia","volume":"23","author":"Wu","year":"2025","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"15142","DOI":"10.1038\/s41598-024-65937-x","article-title":"Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification","volume":"14","author":"Sun","year":"2024","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","article-title":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0128-5","article-title":"Itaconate: the poster child of metabolic reprogramming in macrophage function","volume":"19","author":"O\u2019Neill","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e173034","DOI":"10.1172\/JCI173034","article-title":"Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice","volume":"134","author":"Song","year":"2023","journal-title":"J Clin Invest"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101830","article-title":"Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition","volume":"5","author":"Beielstein","year":"2024","journal-title":"Cell Rep Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-024-47096-9","article-title":"Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic Malignancies","volume":"15","author":"Daneshmandi","year":"2024","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-022-00676-9","article-title":"Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumor growth","volume":"4","author":"Zhao","year":"2022","journal-title":"Nat Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103711","article-title":"Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response","volume":"85","author":"Che","year":"2025","journal-title":"Redox Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00217-y","article-title":"Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350418","article-title":"Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemia","volume":"53","author":"Sana","year":"2023","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189344","article-title":"Interactions between cancer cells and tumor-associated macrophages in tumor microenvironment","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1571446","article-title":"Succinylation-related molecular activities in cancer: metabolic adaptations, immune landscape, and prognostic significance in colorectal cancer","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01003-x","article-title":"Bone marrow inflammation in haematological Malignancies","volume":"24","author":"De Jong","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur J Medicinal Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113614","article-title":"AMP-activated protein kinase: an energy sensor and survival mechanism in the reinstatement of metabolic homeostasis","volume":"428","author":"Sharma","year":"2023","journal-title":"Exp Cell Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"key":"B76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"B78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110859","article-title":"Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma","volume":"124","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02391-8","article-title":"IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma","volume":"38","author":"Sun","year":"2024","journal-title":"Leukemia"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.885011","article-title":"Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC\/BCL2 double expressor lymphoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12944-022-01687-x","article-title":"A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia","volume":"21","author":"Zhang","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113320","article-title":"Palmitic acid inhibits macrophage-mediated chemotherapy resistance in multiple myeloma via ALOX12 signaling","volume":"143","author":"Dong","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021119-034513","article-title":"Marrow adipocytes: origin, structure, and function","volume":"82","author":"De Paula","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","article-title":"Obesity and multiple myeloma: emerging mechanisms and perspectives","volume":"92","author":"Tentolouris","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13679-025-00644-w","article-title":"Unraveling obesity and multiple myeloma: insights from epidemiology and molecular mechanisms","volume":"14","author":"Manna","year":"2025","journal-title":"Curr Obes Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101856","article-title":"Bone marrow adipocytes is a new player in supporting myeloma cells proliferation and survival in myeloma microenvironment","volume":"40","author":"Wei","year":"2023","journal-title":"Transl Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2323765","article-title":"Dynamic evolution of bone marrow adipocyte in B cell acute lymphoblastic leukemia: insights from diagnosis to post-chemotherapy","volume":"25","author":"Jia","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35418","article-title":"GREM1 deficiency induced bone marrow adipose niche promotes B-cell acute lymphoblastic leukemia disease progression","volume":"157","author":"Song","year":"2025","journal-title":"Int J Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12964-023-01231-z","article-title":"Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development","volume":"21","author":"Sabbah","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B91","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41375-019-0568-8","article-title":"Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support","volume":"34","author":"Azadniv","year":"2020","journal-title":"Leukemia"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205854","article-title":"DEX-induced SREBF1 promotes BMSCs differentiation into adipocytes to attract and protect residual T-cell acute lymphoblastic leukemia cells after chemotherapy","volume":"10","author":"Jia","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40164-025-00606-x","article-title":"A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche","volume":"14","author":"Ghamlouch","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105811","article-title":"Acute myeloid leukemia cells educate mesenchymal stromal cells toward an adipogenic differentiation propensity with leukemia promotion capabilities","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci Transl Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02209-w","article-title":"Induction of m6A methylation in adipocyte exosomal lncRNAs mediates myeloma drug resistance","volume":"41","author":"Wang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1320497","article-title":"AML alters bone marrow stromal cell osteogenic commitment via notch signaling","volume":"14","author":"Tomasoni","year":"2023","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.259","article-title":"Acute Myeloid Leukemia Transforms the Bone Marrow Niche into a Leukemia-Permissive Microenvironment through Exosome Secretion","volume":"32","author":"Kumar","year":"2018","journal-title":"Leukemia"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2025.107028","article-title":"Role of lysophosphatidic acid in the regulation of immune cells and hematological Malignancies","volume":"180","author":"Gupta","year":"2025","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B100","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2020.04.016","article-title":"Metabolic alterations in the tumor microenvironment and their role in oncogenesis","volume":"484","author":"Eisenberg","year":"2020","journal-title":"Cancer Lett"},{"key":"B101","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cmet.2022.02.011","article-title":"Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma","volume":"34","author":"Kudo","year":"2022","journal-title":"Cell Metab"},{"key":"B102","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12950-020-00254-4","article-title":"Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma","volume":"17","author":"Feng","year":"2020","journal-title":"J Inflammation (Lond)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2499","article-title":"Lysophosphatidic acid receptors 1 and 3 axis governs cellular senescence of mesenchymal stromal cells and promotes growth and vascularization of multiple myeloma","volume":"35","author":"Kanehira","year":"2017","journal-title":"Stem Cells"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101583","article-title":"Neutrophil metabolism in the cancer context","volume":"57","author":"Bodac","year":"2021","journal-title":"Semin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116334","article-title":"Targeting neutrophil extracellular traps: A novel strategy in hematologic Malignancies","volume":"173","author":"Liu","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406359","article-title":"ACSL1 aggravates thromboinflammation by LPC\/LPA metabolic axis in hyperlipidemia associated myocardial ischemia-reperfusion injury","volume":"12","author":"Jiang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844781","article-title":"Lysophosphatidic acid receptor 3 suppress neutrophil extracellular traps production and thrombosis during sepsis","volume":"13","author":"Pei","year":"2022","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02094-5","article-title":"Targeting the sphingosine-1-phosphate pathway: new opportunities in inflammatory bowel disease management","volume":"84","author":"Kitsou","year":"2024","journal-title":"Drugs"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030574","article-title":"The oncogenic lipid sphingosine-1-phosphate impedes the phagocytosis of tumor cells by M1 macrophages in diffuse large B cell lymphoma","volume":"16","author":"Perry","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02589-7","article-title":"S1PR1\/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma","volume":"42","author":"Wang","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.04.004","article-title":"Interrelations of sphingolipid and lysophosphatidate signaling with immune system in ovarian cancer","volume":"17","author":"Meshcheryakova","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108415","article-title":"Lysophospholipids and their producing enzymes: their pathological roles and potential as pathological biomarkers","volume":"246","author":"Yaginuma","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-021-01024-6","article-title":"Lysophosphatidate promotes sphingosine 1-phosphate metabolism and signaling: implications for breast cancer and doxorubicin resistance","volume":"79","author":"Venkatraman","year":"2021","journal-title":"Cell Biochem Biophys"},{"key":"B116","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.drudis.2016.12.003","article-title":"Targeting amino acid metabolism for cancer therapy","volume":"22","author":"Lukey","year":"2017","journal-title":"Drug Discov Today"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Jha","year":"2015","journal-title":"Immunity"},{"key":"B118","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-023-01453-1","article-title":"Amino acid metabolism in immune cells: essential regulators of the effector functions, and promising opportunities to enhance cancer immunotherapy","volume":"16","author":"Yang","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31349","article-title":"Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy","volume":"239","author":"Zhang","year":"2024","journal-title":"J Cell Physiol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1578940","article-title":"Glutamine\u2019s double-edged sword: fueling tumor growth and offering therapeutic hope","volume":"16","author":"Fang","year":"2025","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-bioeng-071516-044546","article-title":"Glutaminolysis: A hallmark of cancer metabolism","volume":"19","author":"Yang","year":"2017","journal-title":"Annu Rev Biomed Eng"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmy084","article-title":"Glutamine metabolism in macrophages: A novel target for obesity\/type 2 diabetes","volume":"10","author":"Ren","year":"2019","journal-title":"Adv Nutr"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.873792","article-title":"Targeting GGT1 eliminates the tumor-promoting effect and enhanced immunosuppressive function of myeloid-derived suppressor cells caused by G-CSF","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B127","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41556-018-0083-6","article-title":"Cancer-Cell-Secreted Exosomal miR-105 Promotes Tumour Growth through the MYC-Dependent Metabolic Reprogramming of Stromal Cells","volume":"20","author":"Yan","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0119","article-title":"Macropinocytosis in cancer-associated fibroblasts is dependent on caMKK2\/ARHGEF2 signaling and functions to support tumor and stromal cell fitness","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-12-4402","article-title":"Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine","volume":"73","author":"Ehsanipour","year":"2013","journal-title":"Cancer Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41420-024-01823-9","article-title":"Crosstalk between autophagy and metabolism: Implications for cell survival in acute myeloid leukemia","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"Bajpai","year":"2016","journal-title":"Oncogene"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-480129","article-title":"Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment","volume":"122","author":"Mussai","year":"2013","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000662","article-title":"The role of myeloid-derived suppressor cells in hematologic Malignancies","volume":"32","author":"Gunes","year":"2020","journal-title":"Curr Opin Oncol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1817431","article-title":"Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway","volume":"62","author":"Qi","year":"2021","journal-title":"Leukemia Lymphoma"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-730614","article-title":"MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia","volume":"129","author":"Pyzer","year":"2017","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40164-023-00399-x","article-title":"Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-na\u00efve diffuse large B-cell lymphoma","volume":"12","author":"Wang","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jncc.2024.10.001","article-title":"Overexpression of ornithine decarboxylase 1 mediates the immune-deserted microenvironment and poor prognosis in diffuse large B-cell lymphoma","volume":"5","author":"Liang","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","article-title":"Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion","volume":"43","author":"Zhu","year":"2025","journal-title":"Cancer Cell"},{"key":"B140","doi-asserted-by":"publisher","first-page":"18741","DOI":"10.1038\/s41598-025-03446-1","article-title":"Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity","volume":"15","author":"Grzybowski","year":"2025","journal-title":"Sci Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103553","article-title":"Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release","volume":"188","author":"Jayaraman","year":"2012","journal-title":"J Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1089\/ars.2019.7958","article-title":"Nitric oxide in hematological cancers: Partner or rival","volume":"34","author":"Vivarelli","year":"2021","journal-title":"Antioxidants Redox Signaling"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176673","article-title":"Inhibiting PRMT1 Protects against CoNV by Regulating Macrophages through the FGF2\/PI3K\/Akt Pathway","volume":"977","author":"Gao","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-19-1020","article-title":"Novel peptidylarginine deiminase 4 (PAD4) inhibitor BMS-P5 blocks formation of neutrophil extracellular traps and delays progression of multiple myeloma","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e0321221","DOI":"10.1371\/journal.pone.0321221","article-title":"Resveratrol decreases extracellular traps (ETs) in acute promyelocytic leukemia (NB4) cells","volume":"20","author":"Vafajoo","year":"2025","journal-title":"PloS One"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363938","article-title":"New Insight into Arginine and Tryptophan Metabolism in Macrophage Activation during Tuberculosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-12-546416","article-title":"CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs","volume":"124","author":"Jitschin","year":"2014","journal-title":"Blood"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-3594","article-title":"Release of IFN\u03b3 by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T cells","volume":"28","author":"Corradi","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900291","article-title":"AhR activation leads to massive mobilization of myeloid-derived suppressor cells with immunosuppressive activity through regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p that target anti-inflammatory genes","volume":"203","author":"Neamah","year":"2019","journal-title":"J Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.651687","article-title":"Investigating the role of indoleamine 2, 3-dioxygenase in acute myeloid leukemia: A systematic review","volume":"12","author":"Wells","year":"2021","journal-title":"Front Immunol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1041388","article-title":"High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia","volume":"57","author":"Mabuchi","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104134","article-title":"A metabolic reprogramming amino acid polymer as an immunosurveillance activator and leukemia targeting drug carrier for T-cell acute lymphoblastic leukemia","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2253-6","article-title":"Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1\/PD-L1 checkpoint blockade","volume":"68","author":"Grauers Wiktorin","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015616","article-title":"Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix-producing cancer-associated fibroblasts","volume":"9","author":"Dessauge","year":"2025","journal-title":"Blood Adv"},{"key":"B157","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","article-title":"Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis","volume":"71","author":"Zhang","year":"2018","journal-title":"Mol Cell"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06256-5","article-title":"Reprogramming tumour-associated macrophages to outcompete cancer cells","volume":"619","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00909-2","article-title":"Linking macrophage metabolism to function in the tumor microenvironment","volume":"6","author":"Jin","year":"2025","journal-title":"Nat Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00262-025-04031-1","article-title":"USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis","volume":"74","author":"Long","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281875","article-title":"Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed\/refractory T-cell lymphoma: Results from a phase I\/II open-label multicenter study","volume":"109","author":"Iyer","year":"2024","journal-title":"Haematologica"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1172\/jci166070","article-title":"Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma","volume":"133","author":"Apollonio","year":"2023","journal-title":"J Clin Invest"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2677","article-title":"Phase II study to determine the antitumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer","volume":"30","author":"Prenen","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9229","article-title":"A first-in-human study of the fibroblast activation protein\u2013targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors","volume":"15","author":"Melero","year":"2023","journal-title":"Sci Transl Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40164-025-00655-2","article-title":"Molecular mechanisms of viral oncogenesis in haematological Malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling","volume":"14","author":"Xiao","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5ma1116-453rr","article-title":"Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia","volume":"102","author":"Liu","year":"2017","journal-title":"J Leukocyte Biol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2019-125970","article-title":"Interim analysis of a phase II study of the glutaminase inhibitor telaglenastat (CB-839) in combination with azacitidine in advanced myelodysplastic syndrome (MDS)","volume":"134","author":"Guerra","year":"2019","journal-title":"Blood"},{"key":"B169","doi-asserted-by":"publisher","first-page":"e70113","DOI":"10.1002\/cncr.70113","article-title":"A tour of leukemia progress in 2025, viewed through the MD anderson leukemia research lens","volume":"131","author":"Kantarjian","year":"2025","journal-title":"Cancer"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025016399","article-title":"Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML","volume":"9","author":"Montesinos","year":"2025","journal-title":"Blood Adv"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312054","article-title":"Daratumumab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"390","author":"Sonneveld","year":"2024","journal-title":"New Engl J Med"},{"key":"B172","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-021-01847-4","article-title":"What is the prospect of indoleamine 2, 3-dioxygenase 1 inhibition in cancer? Extrapolation from the past","volume":"40","author":"Yao","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1623436","article-title":"Targeting myeloid cells to improve cancer immune therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0291","article-title":"Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia","volume":"84","author":"Monteith","year":"2024","journal-title":"Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-019-0249-1","article-title":"Mebendazole elicits potent antimyeloma activity by inhibiting the USP5\/c-maf axis","volume":"40","author":"Chen","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110451","article-title":"Notch-mediated lactate metabolism regulates MDSC development through the hes1\/MCT2\/c-jun axis","volume":"38","author":"Zhao","year":"2022","journal-title":"Cell Rep"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102102","article-title":"Predicting lymphoma prognosis using machine learning-based genes associated with lactylation","volume":"49","author":"Zhu","year":"2024","journal-title":"Transl Oncol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1645","article-title":"Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells","volume":"77","author":"Tabe","year":"2017","journal-title":"Cancer Res"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.169946","article-title":"CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting","volume":"103","author":"Landberg","year":"2018","journal-title":"Haematologica"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101592","article-title":"A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML","volume":"5","author":"Guo","year":"2024","journal-title":"Cell Rep Med"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215946","article-title":"Lysophosphatidic acid-induced amphiregulin secretion by cancer-associated fibroblasts augments cancer cell invasion","volume":"551","author":"Jeong","year":"2022","journal-title":"Cancer Lett"},{"key":"B183","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10495-022-01723-2","article-title":"Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response","volume":"27","author":"Gupta","year":"2022","journal-title":"Apoptosis"},{"key":"B184","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/s41467-023-38933-4","article-title":"Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity","volume":"14","author":"Turner","year":"2023","journal-title":"Nat Commun"},{"key":"B185","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-020-0117-y","article-title":"The agpat4\/LPA axis in colorectal cancer cells regulates antitumor responses via P38\/P65 signaling in macrophages","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1186\/s12967-024-05779-3","article-title":"Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004041","article-title":"ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment","volume":"5","author":"Chiu","year":"2021","journal-title":"Blood Adv"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12557","article-title":"Amino acid metabolism: Challenges and opportunities for the therapeutic treatment of leukemia and lymphoma","volume":"100","author":"Liao","year":"2022","journal-title":"Immunol Cell Biol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00688","article-title":"Metabolic approaches to rescue antitumor V\u03b39V\u03b42 T-cell functions in multiple myeloma","volume":"11","author":"Castella","year":"2020","journal-title":"Front Immunol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113995","article-title":"ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition","volume":"43","author":"Zou","year":"2024","journal-title":"Cell Rep"},{"key":"B191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2018.01.006","article-title":"Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies","volume":"442","author":"Shariatpanahi","year":"2018","journal-title":"J Theor Biol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02676-2","article-title":"Melatonin modulates L-arginine metabolism in tumor-associated macrophages by targeting arginase 1 in lymphoma","volume":"397","author":"Kumari","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.968208","article-title":"Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma","volume":"12","author":"Trudu","year":"2022","journal-title":"Front Oncol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J immunotherapy Cancer"},{"key":"B195","doi-asserted-by":"publisher","first-page":"19660","DOI":"10.1038\/s41419-022-05021-2","article-title":"Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity","volume":"12","author":"Ramji","year":"2022","journal-title":"Sci Rep"},{"key":"B196","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41419-022-05021-2","article-title":"IDO1 plays a tumor-promoting role via MDM2-mediated suppression of the p53 pathway in diffuse large B-cell lymphoma","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-247","article-title":"Indoleamine 2, 3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma","volume":"10","author":"Bonanno","year":"2012","journal-title":"J Transl Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081899","article-title":"IDO1-targeted therapy does not control disease development in the e\u00b5-TCL1 mouse model of chronic lymphocytic leukemia","volume":"13","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"Cancers"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine Tumor Targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv Mater"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12080","article-title":"Targeting lactate dehydrogenase a (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia","volume":"40","author":"Yu","year":"2020","journal-title":"Cancer Commun (Lond)"},{"key":"B201","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40170-025-00392-4","article-title":"Lactate dehydrogenase a-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival","volume":"13","author":"Erdem","year":"2025","journal-title":"Cancer Metab"},{"key":"B202","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12032-020-01394-6","article-title":"Acute myeloid leukemia sensitivity to metabolic inhibitors: Glycolysis showed to be a better therapeutic target","volume":"37","author":"Lapa","year":"2020","journal-title":"Med Oncol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2106","article-title":"A novel l-asparaginase with low l-glutaminase coactivity is highly efficacious against both T- and B-cell acute lymphoblastic leukemias","volume":"78","author":"Nguyen","year":"2018","journal-title":"vivo Cancer Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-1329","article-title":"Glutaminase activity of L-asparaginase contributes to durable preclinical activity against acute lymphoblastic leukemia","volume":"18","author":"Chan","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci Transl Med"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12690","article-title":"Targeting of cell metabolism in human acute myeloid leukemia--more than targeting of isocitrate dehydrogenase mutations and PI3K\/AKT\/mTOR signaling","volume":"96","author":"Hauge","year":"2016","journal-title":"Eur J Haematol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3390\/applbiosci4010016","article-title":"Advancements in nanotechnology for targeted and controlled drug delivery in hematologic Malignancies: Shaping the future of targeted therapeutics","volume":"4","author":"Mahmoud","year":"2025","journal-title":"Appl Biosci"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300153","article-title":"Tumor therapy strategies based on microenvironment-specific responsive nanomaterials","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv Healthcare Mat"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c02803","article-title":"Tumor microenvironment mediated spermidine-metal-immunopeptide nanocomplex for boosting ferroptotic immunotherapy of lymphoma","volume":"17","author":"Nie","year":"2023","journal-title":"ACS Nano"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.04.005","article-title":"Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane","volume":"145","author":"Liang","year":"2022","journal-title":"Acta Biomaterialia"},{"key":"B211","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/02652048.2021.1876175","article-title":"Bortezomib-loaded lipidic-nano drug delivery systems; formulation, therapeutic efficacy, and pharmacokinetics","volume":"38","author":"Mahmoudian","year":"2021","journal-title":"J Microencapsulation"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202301748","article-title":"Encapsulation of nano-bortezomib in apoptotic stem cell-derived vesicles for the treatment of multiple myeloma","volume":"19","author":"Cao","year":"2023","journal-title":"Small"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202401495","article-title":"Biointerface-engineered hybrid nanovesicles for targeted reprogramming of tumor microenvironment","volume":"36","author":"Zhen","year":"2024","journal-title":"Adv Mat"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c01215","article-title":"Multifunctional calcium\u2013manganese nanomodulator provides antitumor treatment and improved immunotherapy via reprogramming of the tumor microenvironment","volume":"17","author":"Luo","year":"2023","journal-title":"ACS Nano"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202406860","article-title":"Dual oxygen-supply immunosuppression-inhibiting nanomedicine to avoid the intratumoral recruitment of myeloid-derived suppressor cells","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1034257","article-title":"Mechanisms of CAR T cell exhaustion and current counteraction strategies","volume":"10","author":"Zhu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004500","article-title":"Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity","volume":"136","author":"Fultang","year":"2020","journal-title":"Blood"},{"key":"B218","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","article-title":"Olaparib suppresses MDSC recruitment via SDF1\u03b1\/CXCR4 axis to improve the anti-tumor efficacy of CAR-T cells on breast cancer in mice","volume":"29","author":"Sun","year":"2021","journal-title":"Mol Ther"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.09.010","article-title":"CXCR4-Modified CAR-T Cells Suppresses MDSCs Recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 Axis to Enhance Efficacy against Pancreatic Cancer","volume":"31","author":"Sun","year":"2023","journal-title":"Mol Ther"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1039\/d1bm01982a","article-title":"Multifunctional theranostic nanoparticles for multi-modal imaging-guided CAR-T immunotherapy and chemo-photothermal combinational therapy of non-hodgkin\u2019s lymphoma","volume":"10","author":"Shi","year":"2022","journal-title":"Biomater Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:03:32Z","timestamp":1774368212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":220,"alternative-id":["10.3389\/fimmu.2026.1773233"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1773233","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1773233"}}